Skip to content
Screener

CorMedix CRMD EV / EBITDA

EV / EBITDA at other companies

Pfizer logo
PfizerPFE
12.9×—
Merck & Co. logo
Merck & Co.MRK
40.1×+29.3×
Merit Medical Systems logo
Merit Medical SystemsMMSI
14.2×-10.5×
IAR
Integra LifeSciencesIART
14.9×—
ICU Medical logo
ICU MedicalICUI
17.1×+1.5×
TFX
TeleflexTFX
29.2×+13.5×

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$583.68M-22.4%
P/E3.2×—
P/S1.5×-4.7×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%—
Net margin45.2%—
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%—
Debt / equity0×0.0×
Current ratio3×-1.2×

Where this comes from

Calculated from CorMedix’s reported figures.

enterprise value/ebitda=4.7×

Based on the most recent quarter.

The source filing: CorMedix’s 10-Q, filed May 14, 2026. Open the filing →

Filed
May 14, 2026, 8:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001410098-26-000021

FAQ

What is CorMedix's EV / EBITDA?
CorMedix (CRMD) reported EV / EBITDA of 4.7× in Q4 2025.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Ask your AI about CorMedix's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude